March 8, 2018 / 5:26 AM / 4 months ago

Therapeutic brands help lift Aspen Pharmacare's H1 profit

JOHANNESBURG, March 8 (Reuters) - South Africa’s Aspen Pharmacare said on Thursday first-half earnings rose 26 percent, buoyed by a strong result from therapeutic focused brands.

Aspen, with presence in 50 countries spanning six continents, said normalised headline earnings per share (HEPS) for the six-months ended Dec.31, rose to 872 cents from 692 cents.

HEPS is the main profit gauge in South Africa, which strips out certain one-off items.

Group revenue grew 11 percent to 21.9 billion rand ($1.85 billion) from 19.8 billion rand.

$1 = 11.8355 rand Reporting by Nqobile Dludla; Editing by Biju Dwarakanath

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below